Global Psilocybin Assisted Therapy Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Psilocybin Assisted Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Psilocybin Assisted Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Psilocybin Assisted Therapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Psilocybin Assisted Therapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Psilocybin Assisted Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Psilocybin Assisted Therapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Psilocybin Assisted Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Psilocybin Assisted Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MindMed, Compass Pathways, ATAI Life Sciences, Field Trip and DemeRx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Psilocybin Assisted Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Psilocybin Assisted Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Psilocybin Assisted Therapy, with price, sales, revenue and global market share of Psilocybin Assisted Therapy from 2018 to 2023.
Chapter 3, the Psilocybin Assisted Therapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Psilocybin Assisted Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Psilocybin Assisted Therapy market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Psilocybin Assisted Therapy.
Chapter 14 and 15, to describe Psilocybin Assisted Therapy sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Psilocybin Assisted Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Psilocybin Assisted Therapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Psilocybin Assisted Therapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Psilocybin Assisted Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Psilocybin Assisted Therapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Psilocybin Assisted Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Psilocybin Assisted Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MindMed, Compass Pathways, ATAI Life Sciences, Field Trip and DemeRx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Psilocybin Assisted Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Natural
- Synthetic
- Cluster Headaches
- Anxiety Disorders
- Psychiatric Disorders
- MindMed
- Compass Pathways
- ATAI Life Sciences
- Field Trip
- DemeRx
- Eleusis
- Hikma Pharmaceuticals PLC
- Pfizer
- Verrian
- Jazz Pharmaceuticals
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Psilocybin Assisted Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Psilocybin Assisted Therapy, with price, sales, revenue and global market share of Psilocybin Assisted Therapy from 2018 to 2023.
Chapter 3, the Psilocybin Assisted Therapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Psilocybin Assisted Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Psilocybin Assisted Therapy market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Psilocybin Assisted Therapy.
Chapter 14 and 15, to describe Psilocybin Assisted Therapy sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Psilocybin Assisted Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Psilocybin Assisted Therapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Natural
1.3.3 Synthetic
1.4 Market Analysis by Application
1.4.1 Overview: Global Psilocybin Assisted Therapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cluster Headaches
1.4.3 Anxiety Disorders
1.4.4 Psychiatric Disorders
1.5 Global Psilocybin Assisted Therapy Market Size & Forecast
1.5.1 Global Psilocybin Assisted Therapy Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Psilocybin Assisted Therapy Sales Quantity (2018-2029)
1.5.3 Global Psilocybin Assisted Therapy Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 MindMed
2.1.1 MindMed Details
2.1.2 MindMed Major Business
2.1.3 MindMed Psilocybin Assisted Therapy Product and Services
2.1.4 MindMed Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 MindMed Recent Developments/Updates
2.2 Compass Pathways
2.2.1 Compass Pathways Details
2.2.2 Compass Pathways Major Business
2.2.3 Compass Pathways Psilocybin Assisted Therapy Product and Services
2.2.4 Compass Pathways Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Compass Pathways Recent Developments/Updates
2.3 ATAI Life Sciences
2.3.1 ATAI Life Sciences Details
2.3.2 ATAI Life Sciences Major Business
2.3.3 ATAI Life Sciences Psilocybin Assisted Therapy Product and Services
2.3.4 ATAI Life Sciences Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ATAI Life Sciences Recent Developments/Updates
2.4 Field Trip
2.4.1 Field Trip Details
2.4.2 Field Trip Major Business
2.4.3 Field Trip Psilocybin Assisted Therapy Product and Services
2.4.4 Field Trip Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Field Trip Recent Developments/Updates
2.5 DemeRx
2.5.1 DemeRx Details
2.5.2 DemeRx Major Business
2.5.3 DemeRx Psilocybin Assisted Therapy Product and Services
2.5.4 DemeRx Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 DemeRx Recent Developments/Updates
2.6 Eleusis
2.6.1 Eleusis Details
2.6.2 Eleusis Major Business
2.6.3 Eleusis Psilocybin Assisted Therapy Product and Services
2.6.4 Eleusis Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Eleusis Recent Developments/Updates
2.7 Hikma Pharmaceuticals PLC
2.7.1 Hikma Pharmaceuticals PLC Details
2.7.2 Hikma Pharmaceuticals PLC Major Business
2.7.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product and Services
2.7.4 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Psilocybin Assisted Therapy Product and Services
2.8.4 Pfizer Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments/Updates
2.9 Verrian
2.9.1 Verrian Details
2.9.2 Verrian Major Business
2.9.3 Verrian Psilocybin Assisted Therapy Product and Services
2.9.4 Verrian Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Verrian Recent Developments/Updates
2.10 Jazz Pharmaceuticals
2.10.1 Jazz Pharmaceuticals Details
2.10.2 Jazz Pharmaceuticals Major Business
2.10.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product and Services
2.10.4 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jazz Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PSILOCYBIN ASSISTED THERAPY BY MANUFACTURER
3.1 Global Psilocybin Assisted Therapy Sales Quantity by Manufacturer (2018-2023)
3.2 Global Psilocybin Assisted Therapy Revenue by Manufacturer (2018-2023)
3.3 Global Psilocybin Assisted Therapy Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Psilocybin Assisted Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Psilocybin Assisted Therapy Manufacturer Market Share in 2022
3.4.2 Top 6 Psilocybin Assisted Therapy Manufacturer Market Share in 2022
3.5 Psilocybin Assisted Therapy Market: Overall Company Footprint Analysis
3.5.1 Psilocybin Assisted Therapy Market: Region Footprint
3.5.2 Psilocybin Assisted Therapy Market: Company Product Type Footprint
3.5.3 Psilocybin Assisted Therapy Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Psilocybin Assisted Therapy Market Size by Region
4.1.1 Global Psilocybin Assisted Therapy Sales Quantity by Region (2018-2029)
4.1.2 Global Psilocybin Assisted Therapy Consumption Value by Region (2018-2029)
4.1.3 Global Psilocybin Assisted Therapy Average Price by Region (2018-2029)
4.2 North America Psilocybin Assisted Therapy Consumption Value (2018-2029)
4.3 Europe Psilocybin Assisted Therapy Consumption Value (2018-2029)
4.4 Asia-Pacific Psilocybin Assisted Therapy Consumption Value (2018-2029)
4.5 South America Psilocybin Assisted Therapy Consumption Value (2018-2029)
4.6 Middle East and Africa Psilocybin Assisted Therapy Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Psilocybin Assisted Therapy Sales Quantity by Type (2018-2029)
5.2 Global Psilocybin Assisted Therapy Consumption Value by Type (2018-2029)
5.3 Global Psilocybin Assisted Therapy Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Psilocybin Assisted Therapy Sales Quantity by Application (2018-2029)
6.2 Global Psilocybin Assisted Therapy Consumption Value by Application (2018-2029)
6.3 Global Psilocybin Assisted Therapy Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Psilocybin Assisted Therapy Sales Quantity by Type (2018-2029)
7.2 North America Psilocybin Assisted Therapy Sales Quantity by Application (2018-2029)
7.3 North America Psilocybin Assisted Therapy Market Size by Country
7.3.1 North America Psilocybin Assisted Therapy Sales Quantity by Country (2018-2029)
7.3.2 North America Psilocybin Assisted Therapy Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Psilocybin Assisted Therapy Sales Quantity by Type (2018-2029)
8.2 Europe Psilocybin Assisted Therapy Sales Quantity by Application (2018-2029)
8.3 Europe Psilocybin Assisted Therapy Market Size by Country
8.3.1 Europe Psilocybin Assisted Therapy Sales Quantity by Country (2018-2029)
8.3.2 Europe Psilocybin Assisted Therapy Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Psilocybin Assisted Therapy Market Size by Region
9.3.1 Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Psilocybin Assisted Therapy Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Psilocybin Assisted Therapy Sales Quantity by Type (2018-2029)
10.2 South America Psilocybin Assisted Therapy Sales Quantity by Application (2018-2029)
10.3 South America Psilocybin Assisted Therapy Market Size by Country
10.3.1 South America Psilocybin Assisted Therapy Sales Quantity by Country (2018-2029)
10.3.2 South America Psilocybin Assisted Therapy Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Psilocybin Assisted Therapy Market Size by Country
11.3.1 Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Psilocybin Assisted Therapy Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Psilocybin Assisted Therapy Market Drivers
12.2 Psilocybin Assisted Therapy Market Restraints
12.3 Psilocybin Assisted Therapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Psilocybin Assisted Therapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of Psilocybin Assisted Therapy
13.3 Psilocybin Assisted Therapy Production Process
13.4 Psilocybin Assisted Therapy Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Psilocybin Assisted Therapy Typical Distributors
14.3 Psilocybin Assisted Therapy Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Psilocybin Assisted Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Psilocybin Assisted Therapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Natural
1.3.3 Synthetic
1.4 Market Analysis by Application
1.4.1 Overview: Global Psilocybin Assisted Therapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cluster Headaches
1.4.3 Anxiety Disorders
1.4.4 Psychiatric Disorders
1.5 Global Psilocybin Assisted Therapy Market Size & Forecast
1.5.1 Global Psilocybin Assisted Therapy Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Psilocybin Assisted Therapy Sales Quantity (2018-2029)
1.5.3 Global Psilocybin Assisted Therapy Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 MindMed
2.1.1 MindMed Details
2.1.2 MindMed Major Business
2.1.3 MindMed Psilocybin Assisted Therapy Product and Services
2.1.4 MindMed Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 MindMed Recent Developments/Updates
2.2 Compass Pathways
2.2.1 Compass Pathways Details
2.2.2 Compass Pathways Major Business
2.2.3 Compass Pathways Psilocybin Assisted Therapy Product and Services
2.2.4 Compass Pathways Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Compass Pathways Recent Developments/Updates
2.3 ATAI Life Sciences
2.3.1 ATAI Life Sciences Details
2.3.2 ATAI Life Sciences Major Business
2.3.3 ATAI Life Sciences Psilocybin Assisted Therapy Product and Services
2.3.4 ATAI Life Sciences Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ATAI Life Sciences Recent Developments/Updates
2.4 Field Trip
2.4.1 Field Trip Details
2.4.2 Field Trip Major Business
2.4.3 Field Trip Psilocybin Assisted Therapy Product and Services
2.4.4 Field Trip Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Field Trip Recent Developments/Updates
2.5 DemeRx
2.5.1 DemeRx Details
2.5.2 DemeRx Major Business
2.5.3 DemeRx Psilocybin Assisted Therapy Product and Services
2.5.4 DemeRx Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 DemeRx Recent Developments/Updates
2.6 Eleusis
2.6.1 Eleusis Details
2.6.2 Eleusis Major Business
2.6.3 Eleusis Psilocybin Assisted Therapy Product and Services
2.6.4 Eleusis Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Eleusis Recent Developments/Updates
2.7 Hikma Pharmaceuticals PLC
2.7.1 Hikma Pharmaceuticals PLC Details
2.7.2 Hikma Pharmaceuticals PLC Major Business
2.7.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product and Services
2.7.4 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Psilocybin Assisted Therapy Product and Services
2.8.4 Pfizer Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments/Updates
2.9 Verrian
2.9.1 Verrian Details
2.9.2 Verrian Major Business
2.9.3 Verrian Psilocybin Assisted Therapy Product and Services
2.9.4 Verrian Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Verrian Recent Developments/Updates
2.10 Jazz Pharmaceuticals
2.10.1 Jazz Pharmaceuticals Details
2.10.2 Jazz Pharmaceuticals Major Business
2.10.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product and Services
2.10.4 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jazz Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PSILOCYBIN ASSISTED THERAPY BY MANUFACTURER
3.1 Global Psilocybin Assisted Therapy Sales Quantity by Manufacturer (2018-2023)
3.2 Global Psilocybin Assisted Therapy Revenue by Manufacturer (2018-2023)
3.3 Global Psilocybin Assisted Therapy Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Psilocybin Assisted Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Psilocybin Assisted Therapy Manufacturer Market Share in 2022
3.4.2 Top 6 Psilocybin Assisted Therapy Manufacturer Market Share in 2022
3.5 Psilocybin Assisted Therapy Market: Overall Company Footprint Analysis
3.5.1 Psilocybin Assisted Therapy Market: Region Footprint
3.5.2 Psilocybin Assisted Therapy Market: Company Product Type Footprint
3.5.3 Psilocybin Assisted Therapy Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Psilocybin Assisted Therapy Market Size by Region
4.1.1 Global Psilocybin Assisted Therapy Sales Quantity by Region (2018-2029)
4.1.2 Global Psilocybin Assisted Therapy Consumption Value by Region (2018-2029)
4.1.3 Global Psilocybin Assisted Therapy Average Price by Region (2018-2029)
4.2 North America Psilocybin Assisted Therapy Consumption Value (2018-2029)
4.3 Europe Psilocybin Assisted Therapy Consumption Value (2018-2029)
4.4 Asia-Pacific Psilocybin Assisted Therapy Consumption Value (2018-2029)
4.5 South America Psilocybin Assisted Therapy Consumption Value (2018-2029)
4.6 Middle East and Africa Psilocybin Assisted Therapy Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Psilocybin Assisted Therapy Sales Quantity by Type (2018-2029)
5.2 Global Psilocybin Assisted Therapy Consumption Value by Type (2018-2029)
5.3 Global Psilocybin Assisted Therapy Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Psilocybin Assisted Therapy Sales Quantity by Application (2018-2029)
6.2 Global Psilocybin Assisted Therapy Consumption Value by Application (2018-2029)
6.3 Global Psilocybin Assisted Therapy Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Psilocybin Assisted Therapy Sales Quantity by Type (2018-2029)
7.2 North America Psilocybin Assisted Therapy Sales Quantity by Application (2018-2029)
7.3 North America Psilocybin Assisted Therapy Market Size by Country
7.3.1 North America Psilocybin Assisted Therapy Sales Quantity by Country (2018-2029)
7.3.2 North America Psilocybin Assisted Therapy Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Psilocybin Assisted Therapy Sales Quantity by Type (2018-2029)
8.2 Europe Psilocybin Assisted Therapy Sales Quantity by Application (2018-2029)
8.3 Europe Psilocybin Assisted Therapy Market Size by Country
8.3.1 Europe Psilocybin Assisted Therapy Sales Quantity by Country (2018-2029)
8.3.2 Europe Psilocybin Assisted Therapy Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Psilocybin Assisted Therapy Market Size by Region
9.3.1 Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Psilocybin Assisted Therapy Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Psilocybin Assisted Therapy Sales Quantity by Type (2018-2029)
10.2 South America Psilocybin Assisted Therapy Sales Quantity by Application (2018-2029)
10.3 South America Psilocybin Assisted Therapy Market Size by Country
10.3.1 South America Psilocybin Assisted Therapy Sales Quantity by Country (2018-2029)
10.3.2 South America Psilocybin Assisted Therapy Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Psilocybin Assisted Therapy Market Size by Country
11.3.1 Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Psilocybin Assisted Therapy Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Psilocybin Assisted Therapy Market Drivers
12.2 Psilocybin Assisted Therapy Market Restraints
12.3 Psilocybin Assisted Therapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Psilocybin Assisted Therapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of Psilocybin Assisted Therapy
13.3 Psilocybin Assisted Therapy Production Process
13.4 Psilocybin Assisted Therapy Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Psilocybin Assisted Therapy Typical Distributors
14.3 Psilocybin Assisted Therapy Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Psilocybin Assisted Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Psilocybin Assisted Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. MindMed Basic Information, Manufacturing Base and Competitors
Table 4. MindMed Major Business
Table 5. MindMed Psilocybin Assisted Therapy Product and Services
Table 6. MindMed Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. MindMed Recent Developments/Updates
Table 8. Compass Pathways Basic Information, Manufacturing Base and Competitors
Table 9. Compass Pathways Major Business
Table 10. Compass Pathways Psilocybin Assisted Therapy Product and Services
Table 11. Compass Pathways Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Compass Pathways Recent Developments/Updates
Table 13. ATAI Life Sciences Basic Information, Manufacturing Base and Competitors
Table 14. ATAI Life Sciences Major Business
Table 15. ATAI Life Sciences Psilocybin Assisted Therapy Product and Services
Table 16. ATAI Life Sciences Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. ATAI Life Sciences Recent Developments/Updates
Table 18. Field Trip Basic Information, Manufacturing Base and Competitors
Table 19. Field Trip Major Business
Table 20. Field Trip Psilocybin Assisted Therapy Product and Services
Table 21. Field Trip Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Field Trip Recent Developments/Updates
Table 23. DemeRx Basic Information, Manufacturing Base and Competitors
Table 24. DemeRx Major Business
Table 25. DemeRx Psilocybin Assisted Therapy Product and Services
Table 26. DemeRx Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. DemeRx Recent Developments/Updates
Table 28. Eleusis Basic Information, Manufacturing Base and Competitors
Table 29. Eleusis Major Business
Table 30. Eleusis Psilocybin Assisted Therapy Product and Services
Table 31. Eleusis Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Eleusis Recent Developments/Updates
Table 33. Hikma Pharmaceuticals PLC Basic Information, Manufacturing Base and Competitors
Table 34. Hikma Pharmaceuticals PLC Major Business
Table 35. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product and Services
Table 36. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Psilocybin Assisted Therapy Product and Services
Table 41. Pfizer Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Pfizer Recent Developments/Updates
Table 43. Verrian Basic Information, Manufacturing Base and Competitors
Table 44. Verrian Major Business
Table 45. Verrian Psilocybin Assisted Therapy Product and Services
Table 46. Verrian Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Verrian Recent Developments/Updates
Table 48. Jazz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Jazz Pharmaceuticals Major Business
Table 50. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product and Services
Table 51. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jazz Pharmaceuticals Recent Developments/Updates
Table 53. Global Psilocybin Assisted Therapy Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Psilocybin Assisted Therapy Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Psilocybin Assisted Therapy Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 56. Market Position of Manufacturers in Psilocybin Assisted Therapy, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Psilocybin Assisted Therapy Production Site of Key Manufacturer
Table 58. Psilocybin Assisted Therapy Market: Company Product Type Footprint
Table 59. Psilocybin Assisted Therapy Market: Company Product Application Footprint
Table 60. Psilocybin Assisted Therapy New Market Entrants and Barriers to Market Entry
Table 61. Psilocybin Assisted Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Psilocybin Assisted Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Psilocybin Assisted Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Psilocybin Assisted Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Psilocybin Assisted Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Psilocybin Assisted Therapy Average Price by Region (2018-2023) & (USD/Unit)
Table 67. Global Psilocybin Assisted Therapy Average Price by Region (2024-2029) & (USD/Unit)
Table 68. Global Psilocybin Assisted Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Psilocybin Assisted Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Psilocybin Assisted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Psilocybin Assisted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Psilocybin Assisted Therapy Average Price by Type (2018-2023) & (USD/Unit)
Table 73. Global Psilocybin Assisted Therapy Average Price by Type (2024-2029) & (USD/Unit)
Table 74. Global Psilocybin Assisted Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Psilocybin Assisted Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Psilocybin Assisted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Psilocybin Assisted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Psilocybin Assisted Therapy Average Price by Application (2018-2023) & (USD/Unit)
Table 79. Global Psilocybin Assisted Therapy Average Price by Application (2024-2029) & (USD/Unit)
Table 80. North America Psilocybin Assisted Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Psilocybin Assisted Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Psilocybin Assisted Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Psilocybin Assisted Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Psilocybin Assisted Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Psilocybin Assisted Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Psilocybin Assisted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Psilocybin Assisted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Psilocybin Assisted Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Psilocybin Assisted Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Psilocybin Assisted Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Psilocybin Assisted Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Psilocybin Assisted Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Psilocybin Assisted Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Psilocybin Assisted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Psilocybin Assisted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Psilocybin Assisted Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Psilocybin Assisted Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Psilocybin Assisted Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Psilocybin Assisted Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Psilocybin Assisted Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Psilocybin Assisted Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Psilocybin Assisted Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Psilocybin Assisted Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Psilocybin Assisted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Psilocybin Assisted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Psilocybin Assisted Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Psilocybin Assisted Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Psilocybin Assisted Therapy Raw Material
Table 121. Key Manufacturers of Psilocybin Assisted Therapy Raw Materials
Table 122. Psilocybin Assisted Therapy Typical Distributors
Table 123. Psilocybin Assisted Therapy Typical Customers
Table 1. Global Psilocybin Assisted Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Psilocybin Assisted Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. MindMed Basic Information, Manufacturing Base and Competitors
Table 4. MindMed Major Business
Table 5. MindMed Psilocybin Assisted Therapy Product and Services
Table 6. MindMed Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. MindMed Recent Developments/Updates
Table 8. Compass Pathways Basic Information, Manufacturing Base and Competitors
Table 9. Compass Pathways Major Business
Table 10. Compass Pathways Psilocybin Assisted Therapy Product and Services
Table 11. Compass Pathways Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Compass Pathways Recent Developments/Updates
Table 13. ATAI Life Sciences Basic Information, Manufacturing Base and Competitors
Table 14. ATAI Life Sciences Major Business
Table 15. ATAI Life Sciences Psilocybin Assisted Therapy Product and Services
Table 16. ATAI Life Sciences Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. ATAI Life Sciences Recent Developments/Updates
Table 18. Field Trip Basic Information, Manufacturing Base and Competitors
Table 19. Field Trip Major Business
Table 20. Field Trip Psilocybin Assisted Therapy Product and Services
Table 21. Field Trip Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Field Trip Recent Developments/Updates
Table 23. DemeRx Basic Information, Manufacturing Base and Competitors
Table 24. DemeRx Major Business
Table 25. DemeRx Psilocybin Assisted Therapy Product and Services
Table 26. DemeRx Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. DemeRx Recent Developments/Updates
Table 28. Eleusis Basic Information, Manufacturing Base and Competitors
Table 29. Eleusis Major Business
Table 30. Eleusis Psilocybin Assisted Therapy Product and Services
Table 31. Eleusis Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Eleusis Recent Developments/Updates
Table 33. Hikma Pharmaceuticals PLC Basic Information, Manufacturing Base and Competitors
Table 34. Hikma Pharmaceuticals PLC Major Business
Table 35. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product and Services
Table 36. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Psilocybin Assisted Therapy Product and Services
Table 41. Pfizer Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Pfizer Recent Developments/Updates
Table 43. Verrian Basic Information, Manufacturing Base and Competitors
Table 44. Verrian Major Business
Table 45. Verrian Psilocybin Assisted Therapy Product and Services
Table 46. Verrian Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Verrian Recent Developments/Updates
Table 48. Jazz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Jazz Pharmaceuticals Major Business
Table 50. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product and Services
Table 51. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jazz Pharmaceuticals Recent Developments/Updates
Table 53. Global Psilocybin Assisted Therapy Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Psilocybin Assisted Therapy Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Psilocybin Assisted Therapy Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 56. Market Position of Manufacturers in Psilocybin Assisted Therapy, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Psilocybin Assisted Therapy Production Site of Key Manufacturer
Table 58. Psilocybin Assisted Therapy Market: Company Product Type Footprint
Table 59. Psilocybin Assisted Therapy Market: Company Product Application Footprint
Table 60. Psilocybin Assisted Therapy New Market Entrants and Barriers to Market Entry
Table 61. Psilocybin Assisted Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Psilocybin Assisted Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Psilocybin Assisted Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Psilocybin Assisted Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Psilocybin Assisted Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Psilocybin Assisted Therapy Average Price by Region (2018-2023) & (USD/Unit)
Table 67. Global Psilocybin Assisted Therapy Average Price by Region (2024-2029) & (USD/Unit)
Table 68. Global Psilocybin Assisted Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Psilocybin Assisted Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Psilocybin Assisted Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Psilocybin Assisted Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Psilocybin Assisted Therapy Average Price by Type (2018-2023) & (USD/Unit)
Table 73. Global Psilocybin Assisted Therapy Average Price by Type (2024-2029) & (USD/Unit)
Table 74. Global Psilocybin Assisted Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Psilocybin Assisted Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Psilocybin Assisted Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Psilocybin Assisted Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Psilocybin Assisted Therapy Average Price by Application (2018-2023) & (USD/Unit)
Table 79. Global Psilocybin Assisted Therapy Average Price by Application (2024-2029) & (USD/Unit)
Table 80. North America Psilocybin Assisted Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Psilocybin Assisted Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Psilocybin Assisted Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Psilocybin Assisted Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Psilocybin Assisted Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Psilocybin Assisted Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Psilocybin Assisted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Psilocybin Assisted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Psilocybin Assisted Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Psilocybin Assisted Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Psilocybin Assisted Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Psilocybin Assisted Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Psilocybin Assisted Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Psilocybin Assisted Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Psilocybin Assisted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Psilocybin Assisted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Psilocybin Assisted Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Psilocybin Assisted Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Psilocybin Assisted Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Psilocybin Assisted Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Psilocybin Assisted Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Psilocybin Assisted Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Psilocybin Assisted Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Psilocybin Assisted Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Psilocybin Assisted Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Psilocybin Assisted Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Psilocybin Assisted Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Psilocybin Assisted Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Psilocybin Assisted Therapy Raw Material
Table 121. Key Manufacturers of Psilocybin Assisted Therapy Raw Materials
Table 122. Psilocybin Assisted Therapy Typical Distributors
Table 123. Psilocybin Assisted Therapy Typical Customers
LIST OF FIGURES
Figure 1. Psilocybin Assisted Therapy Picture
Figure 2. Global Psilocybin Assisted Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Psilocybin Assisted Therapy Consumption Value Market Share by Type in 2022
Figure 4. Natural Examples
Figure 5. Synthetic Examples
Figure 6. Global Psilocybin Assisted Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Psilocybin Assisted Therapy Consumption Value Market Share by Application in 2022
Figure 8. Cluster Headaches Examples
Figure 9. Anxiety Disorders Examples
Figure 10. Psychiatric Disorders Examples
Figure 11. Global Psilocybin Assisted Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Psilocybin Assisted Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Psilocybin Assisted Therapy Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Psilocybin Assisted Therapy Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Psilocybin Assisted Therapy Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Psilocybin Assisted Therapy Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Psilocybin Assisted Therapy by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Psilocybin Assisted Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Psilocybin Assisted Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Psilocybin Assisted Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Psilocybin Assisted Therapy Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Psilocybin Assisted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Psilocybin Assisted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Psilocybin Assisted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Psilocybin Assisted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Psilocybin Assisted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Psilocybin Assisted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Psilocybin Assisted Therapy Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Psilocybin Assisted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Psilocybin Assisted Therapy Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Psilocybin Assisted Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Psilocybin Assisted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Psilocybin Assisted Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Psilocybin Assisted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Psilocybin Assisted Therapy Consumption Value Market Share by Region (2018-2029)
Figure 53. China Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Psilocybin Assisted Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Psilocybin Assisted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Psilocybin Assisted Therapy Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Psilocybin Assisted Therapy Market Drivers
Figure 74. Psilocybin Assisted Therapy Market Restraints
Figure 75. Psilocybin Assisted Therapy Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Psilocybin Assisted Therapy in 2022
Figure 78. Manufacturing Process Analysis of Psilocybin Assisted Therapy
Figure 79. Psilocybin Assisted Therapy Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Psilocybin Assisted Therapy Picture
Figure 2. Global Psilocybin Assisted Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Psilocybin Assisted Therapy Consumption Value Market Share by Type in 2022
Figure 4. Natural Examples
Figure 5. Synthetic Examples
Figure 6. Global Psilocybin Assisted Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Psilocybin Assisted Therapy Consumption Value Market Share by Application in 2022
Figure 8. Cluster Headaches Examples
Figure 9. Anxiety Disorders Examples
Figure 10. Psychiatric Disorders Examples
Figure 11. Global Psilocybin Assisted Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Psilocybin Assisted Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Psilocybin Assisted Therapy Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Psilocybin Assisted Therapy Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Psilocybin Assisted Therapy Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Psilocybin Assisted Therapy Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Psilocybin Assisted Therapy by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Psilocybin Assisted Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Psilocybin Assisted Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Psilocybin Assisted Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Psilocybin Assisted Therapy Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Psilocybin Assisted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Psilocybin Assisted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Psilocybin Assisted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Psilocybin Assisted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Psilocybin Assisted Therapy Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Psilocybin Assisted Therapy Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Psilocybin Assisted Therapy Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Psilocybin Assisted Therapy Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Psilocybin Assisted Therapy Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Psilocybin Assisted Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Psilocybin Assisted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Psilocybin Assisted Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Psilocybin Assisted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Psilocybin Assisted Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Psilocybin Assisted Therapy Consumption Value Market Share by Region (2018-2029)
Figure 53. China Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Psilocybin Assisted Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Psilocybin Assisted Therapy Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Psilocybin Assisted Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Psilocybin Assisted Therapy Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Psilocybin Assisted Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Psilocybin Assisted Therapy Market Drivers
Figure 74. Psilocybin Assisted Therapy Market Restraints
Figure 75. Psilocybin Assisted Therapy Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Psilocybin Assisted Therapy in 2022
Figure 78. Manufacturing Process Analysis of Psilocybin Assisted Therapy
Figure 79. Psilocybin Assisted Therapy Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
